Empowerment-based Complementary and Alternative Medicine (ECAM)
CAM
The Establishment of "Empowerment-based Complementary and Alternative Medicine (ECAM) " Educational Program to Improve Complementary and Alternative Medicine(CAM) Health Literacy in Patients With Diabetes: Dilemma Analysis, Integration Into Practice and Outcome Evaluation
1 other identifier
interventional
88
1 country
1
Brief Summary
This phase study will use a randomized trial method to evaluate the performance of the ECAM educational app in the promotion of CAM health literacy and communication among patients with diabetes.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable diabetes
Started May 2024
Shorter than P25 for not_applicable diabetes
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 12, 2024
CompletedFirst Posted
Study publicly available on registry
March 19, 2024
CompletedStudy Start
First participant enrolled
May 17, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 16, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
January 3, 2025
CompletedApril 1, 2025
March 1, 2025
3 months
March 12, 2024
March 26, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Understanding the benefits-risks of complementary therapies (CTs) use scale Alternative Medicine (CAM) use questionnaire
Measure patients' understanding of benefit-risk management on CAM use,The lower the score, the poorer the understanding.
Pre-test (baseline), 2, 3 months after intervention
Quality of life questionnaire
assess patients' satisfaction with various aspects of life while managing diabetes.
Pre-test (baseline), 2, 3 months after intervention
Diabetes Empowerment scale
Measure patients' understanding of benefit-risk management on CAM use, the minimum and maximum values,and higher scores .The minimum is 10,maximum values is 40,The lower the score, the poorer the understanding.
Pre-test (baseline), 2, 3 months after intervention
Study Arms (2)
Empowerment Application for CAM Health Education.
EXPERIMENTALUsing empowerment software applications for complementary and alternative therapy education, explaining the risk factors that need to be considered, and teaching the use of the assistive tool of the empowerment software application
Written Paper for CAM Health Education.
PLACEBO COMPARATORUsing written paper for complementary and alternative therapy education, explaining the risk factors that need to be considered
Interventions
Using empowerment software application for complementary and alternative therapy education, explaining the risk factors that need to be considered, and teaching the use of assistive tool of the empowerment software application
Using written paper for complementary and alternative therapy education and explaining the risk factors that need to be considered
Eligibility Criteria
You may qualify if:
- People over the age of 20
- diagnosis of diabetes at least 12 months before the interview; and
- The use of CAM at least 3 months
- Sufficient mental ability to understand the informed consent form and sign it.
You may not qualify if:
- Participants will be excluded by an assistant researcher if they serious physical condition and hard of hearing and seeing.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
CHENG GUNG MEMORIAL HOSPITAL, Linkou
Taoyuan, Guishan District, 333, Taiwan
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Chang Hsiao Yun, PhD
Chang Gung University of Science and Technology
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Masking Details
- The process of keeping the study group assignment hidden after the allocation to participant, care provider, investigator, outcomes assessor
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- professor
Study Record Dates
First Submitted
March 12, 2024
First Posted
March 19, 2024
Study Start
May 17, 2024
Primary Completion
August 16, 2024
Study Completion
January 3, 2025
Last Updated
April 1, 2025
Record last verified: 2025-03
Data Sharing
- IPD Sharing
- Will not share
there is no plan to make individual participant data (IPD) available to other researchers.